A New First Line Of Attack For Lymphoma
A study led by Manchester scientists has shown promising results for a new treatment approach in follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin's lymphoma, a blood cancer, that usually develops slowly but the majority of patients are diagnosed when their disease is already at an advanced stage. Recent improvements in treatment have included the use of antibodies to specifically target the tumour cells and to stimulate the patient's own immune system to attack their tumor. The use of such antibodies has improved treatment response, but unfortunately most patients still relapse. Radioimmunotherapy – where a radioactive substance is attached to the antibody – has been shown to be successful in treating patients who had previously relapsed. read more